PMV Pharmaceuticals, Inc. PMVP
- rezatapopt — Ovarian Cancer Phase 2
- rezatapopt — Solid Tumors Phase 2
TP53 Y220C (1 companies · 2 programs)
Companies with an active program directed at TP53 Y220C.
Companies with an active program directed at TP53 Y220C.